تاريخ النشر · Saudi Arabia
China’s New Calibration Standard for Urine Meters: What Foreign MedTech Founders Need to Know
China’s market regulator has released a new national metrology standard for urine meters used in ICUs, setting three evaluation dimensions and creating compliance duties for manufacturers, hospitals, and regulators. Foreign founders in medical devices should understand how this affects product design, registration, and post-market obligations.
China’s New Calibration Standard for Urine Meters
On 27 October 2026, China’s State Administration for Market Regulation (SAMR) published the national metrology technical specification Calibration Specification for Urine Meters. The specification addresses a technical gap in the calibration of urine meters and strengthens metrology oversight in critical-care medical devices. For foreign founders active in medical devices, hospital equipment, or digital health in China, the new rule signals tighter expectations for measurement accuracy and lifecycle management.
The source is a CCTV News report republished by SAMR. The specification is framed as a metrology technical norm, not a product registration rule. It applies to urine meters used in intensive care units (ICUs) to continuously collect and record patient urine output. Because urine output is a core indicator for assessing circulation and kidney function in critically ill patients, inaccurate measurement can lead to misjudgment of a patient’s condition and directly endanger safety.
What the Specification Covers
The specification defines three evaluation dimensions for the metrological characteristics of urine meters:
- Alarm function. The device must trigger audible and visual alarms when urine output is too high, too low, or when intermittent urine output exceeds preset thresholds. This helps medical staff quickly identify abnormal changes in a patient’s condition.
- Accuracy of total urine output indication. The specification assesses the measurement performance of cumulative urine volume over a specified period. This is intended to ensure stable and reliable data during long-term continuous monitoring.
- Accuracy of intermittent urine output indication. The specification assesses measurement performance of cumulative urine volume during intermittent periods. The goal is to ensure that real-time displayed or output urine data is accurate and traceable, providing a solid data foundation for clinical diagnosis.
These dimensions are practical benchmarks. Foreign founders whose products include urine monitoring functions should review whether their device design, software algorithms, and alarm logic can meet these expectations when used in Chinese hospitals.
Three Links: Industry, Healthcare Providers, and Regulators
The specification is designed to connect three parties after implementation:
Industry side
Manufacturers are guided to optimize product design against actual clinical conditions and to strengthen metrological performance control at the factory. For foreign founders manufacturing or importing urine meters into China, this means that factory calibration and quality control documentation may become more important in procurement and regulatory checks.
Use side
Medical institutions are guided to establish a periodic traceability mechanism for urine meters, to take responsibility as the primary user, and to manage daily metrological control of equipment in use. Foreign founders selling to Chinese hospitals should anticipate that hospital procurement and biomedical engineering teams may request calibration certificates, traceability records, and maintenance schedules.
Regulatory side
The specification provides market regulators with an authoritative technical basis for metrological supervision and inspection of medical equipment. It supports full-chain metrology oversight of critical-care devices from production to clinical use. This means that local market supervision bureaus may use the specification when conducting inspections, and non-compliance could lead to corrective orders or other administrative measures.
Practical Implications for Foreign Founders
If you are registering or operating a company in China and your business touches medical devices, hospital equipment, or measurement instruments, consider the following practical steps:
- Review product design and labeling. Check whether your urine meter or related monitoring device has alarm thresholds, total volume accuracy, and intermittent volume accuracy that align with the three evaluation dimensions. Update technical files and user manuals where needed.
- Verify calibration and traceability. Ensure that calibration procedures and records are available and traceable. Hospitals may ask for evidence that the device can be calibrated according to the new specification.
- Coordinate with local partners. Distributors, agents, and hospital customers may need updated documentation. Clear communication about metrological performance can support smoother procurement and post-market surveillance.
- Monitor local inspections. Market supervision authorities may conduct metrological inspections of medical equipment. Keep records ready and designate a responsible person for metrology compliance within your China entity.
- Consider registration and standards strategy. Although this specification is a metrology norm, it interacts with medical device registration and hospital acceptance. Foreign founders should map which standards apply to their product category and ensure consistency across filings.
The specification does not create new market access approvals by itself, but it adds a technical layer that hospitals and regulators can use to assess device performance. For foreign founders, the key takeaway is that measurement accuracy and traceability are becoming explicit expectations in China’s critical-care device ecosystem.
What to Watch Next
Implementation will depend on how local market regulators and healthcare providers adopt the specification. Foreign founders should watch for local inspection notices, hospital procurement updates, and any accompanying guidance from SAMR or health authorities. Because the source does not specify transition periods or penalties, companies should seek local advice on timelines and enforcement practices.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
For foreign founders who need help registering and operating a company in China, contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.